Discovering Cures and Improving Cancer Treatments
At Sanford Cancer we are proud pioneers of advanced cancer care and treatment. It's just one of the things we do to help patients recognize victories in their cancer journey. Our commitment to research means we deliver state-of-the-art care by highly trained and skilled professionals. We encourage our patients to participate in both cooperative clinical trials and those offered only at Sanford Cancer. By doing so, they gain access to tomorrow's treatments today.
The clinical trial
With every clinical trial, we get closer to finding a cure. Participation in research studies allow our physicians to provide patients with cutting-edge treatments and advanced care.
We look at clinical trials as an opportunity to offer tomorrow's cancer treatments today. By participating in clinical trials our patients have increased treatment options.
Mastery and innovation
John Lee, MD specializes in head and neck cancer treatments and is committed to advancing cancer therapies through groundbreaking research and clinical trials. Dr. Lee and the head and neck cancer team deliver superior survival rates in the area of head and neck cancer.Learn more about Dr. Lee and his passion for research.
Maria Bell, MD is a gynecologic oncologist and researcher. She provides personalized and advanced care for women with pelvic cancer, precancerous conditions and complex pelvic concerns. She is an internationally recognized leader in robotic surgery.
See how Dr. Bell combines advanced and personalized treatment in her philosophy of care.
Preston Steen, MD is a medical oncologist with expertise in the areas of lymphomas, lung cancer, breast cancer and palliative care. Dr. Steen is one of our lead physicians for research at Sanford Health.
Meet Dr. Steen and hear about why he thinks clinical trials are so important.
Research at Sanford will continue to be the primary path for finding new treatments and cures for cancer.
Contact us for more information on cancer research and clinical trials.
Posted Date: March 2012